SMARTLINQ
LIVE

Serial Number

88662498

Owner

American Society of Clinical Oncology, Inc.

Attorney

Christopher A. Proskey

First Use Date

May 31, 2019

Filing Date

Oct 21, 2019

Add to watchlist:

No watchlists yet
View on USPTO

SMARTLINQ Trademark

Serial Number: 88662498

SMARTLINQ is a trademark filed by American Society of Clinical Oncology, Inc. on October 21, 2019. The trademark is classified under Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

American Society of Clinical Oncology, Inc. (37 trademarks)

2318 Mill Road
Alexandria, VA 22314

Entity Type: 99

CANCERLINQ LLC (5 trademarks)

1120 MASSACHUSETTS AVENUE
CAMBRIDGE, MA 02138

Entity Type: 16

Trademark Details

Filing Date

October 21, 2019

Registration Date

Not Registered

First Use Anywhere

May 31, 2019

First Use in Commerce

May 31, 2019

Goods & Services

Providing internet-based non-downloadable software for use in quality improvement programs for oncology practices, namely, providing quality improvement tools and reports for oncology clinicians, providing data analytics and monitoring to help manage performance of oncology practices against quality performance indicators, and managing and submitting quality performance data for specific quality improvement programs, all of the above excluding software used in connection with the receipt, processing, and submission of quote proposal generation, the receipt, processing, and submission of request for proposals, the generation of contracts in connection with, and arising out of, the quote proposal process, the generating of custom-built documents during the process of implementing, managing and automating the request for proposal process, the payment processing of claims, the generating of custom-built documents during the quote proposal process, and the implementation, management and payment of all healthcare, medical, health insurance, reinsurance, property and casualty, dental, ophthalmology, disability, supplemental health, critical illness, hospital indemnity coverage, and prescription benefits claims

Filing History

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Apr 22, 2026 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Aug 12, 2025 RCSC
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
May 7, 2025 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 7, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 7, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 7, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 7, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 7, 2025 COAR
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Feb 11, 2025 RCSC
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Feb 2, 2024 RCCK
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jan 31, 2024 ASGN
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jan 3, 2024 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
May 1, 2023 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Oct 27, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
Oct 27, 2022 GNSL
SUSPENSION LETTER WRITTEN
Oct 27, 2022 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 20, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 19, 2022 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Aug 19, 2022 ERSI
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
May 11, 2022 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Sep 17, 2021 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Feb 22, 2021 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Aug 10, 2020 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 3, 2020 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 3, 2020 GNSL
SUSPENSION LETTER WRITTEN
Feb 3, 2020 CNSL
ASSIGNED TO EXAMINER
Jan 27, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 25, 2019 NWOS
NEW APPLICATION ENTERED
Oct 24, 2019 NWAP